We read with great interest the report by Fernandéz-Ruiz and colleagues on the outcome of 18 transplant recipients1 with COVID-19, showing a higher case fatality rate than that reported in the general population. Unlike them, we did not observe higher mortality in transplant setting compared to our overall mortality. We collected data of 13 consecutive solid organ transplant recipients admitted to our Center for COVID-19 between February 21st and April 26th, 2020, with a median follow up of 36 days (IQR 25-41). Our patients were younger (median age 59 versus 71 years) and with a shorter median interval from transplantation (5.3 versus 9.3 years) compared to the Spanish case series. The most common comorbidities were hypertension (54%) and diabetes (31%).
This article is protected by copyright. All rights reserved.
COVID-19 in solid organ transplant recipients: A single-center case series from Spain.Am J Transplant. 2020 Apr 16. doi: 10.1111/ajt.15929. Online ahead of print. Am J Transplant. 2020. PMID: 32301155
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.JAMA Cardiol. 2020 May 13:e202159. doi: 10.1001/jamacardio.2020.2159. Online ahead of print. JAMA Cardiol. 2020. PMID: 32402056 Free PMC article.
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA. 2020 Apr 6;323(16):1574-81. doi: 10.1001/jama.2020.5394. Online ahead of print. JAMA. 2020. PMID: 32250385 Free PMC article.
Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature.Tumori. 2016 Dec 1;102(6):574-581. doi: 10.5301/tj.5000557. Epub 2016 Aug 23. Tumori. 2016. PMID: 27647228 Review.
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2. Cochrane Database Syst Rev. 2017. PMID: 28238223 Free PMC article. Review.